Trial Profile
Global LEADERS Trial: head-to-head comparison of a biodegradeable polymer Biolimus A9 eluting stent (BioMatrix Flex) and a durable polymer drug-eluting stent
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Nov 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Umirolimus (Primary) ; Antiplatelets; Aspirin
- Indications Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis; Myocardial infarction; Myocardial ischaemia; Stroke; Thrombosis
- Focus Therapeutic Use
- Acronyms Global LEADERS; LEADERS-II
- 01 Oct 2021 Results (n=6594) of sub-group analysis validating value of GRACE risk score in ACS patients of contemporary PCI era and assessing interaction between patient stratification according to GRACE risk score and antiplatelet treatment strategy published in the Catheterization and Cardiovascular Interventions
- 17 Nov 2020 Results of pooled analysis from five trials (GLOBAL LEADERS, STOP-DAPT2, SMART-CHOICE, TWIGHLIGHT and TICO) presented at the American Heart Association Scientific Sessions 2020
- 01 Jun 2020 Status has been changed to completed.